Research Associate II, Biopharmaceutical (s171)

  • Contract Duration: 12+ months
  • Research & Development
  • Framingham, MA

Website Lenox Executive Search


Biologic Drug Product Development (BDPD) is responsible for the late-stage biopharmaceutical formulation/fill finish process development, process scale up, and technology transfers to manufacturing or CMO. This multi-disciplinary team interacts intensively with many functional groups, including early formulation, process development, analytical, regulatory, clinical, and commercial manufacturing, for the pipeline product development. BDPD has also provided technical support for commercial manufacturing, clinical trial material production, manufacturing deviation investigation, process tech transfer/ validation, and regulatory response.

We are looking for a Research Associate II to join our dept. The incumbent will be responsible for preparing buffer and formulation solutions, conducting protein sample analysis using different analytical techniques, including HPLC, Microflow imaging, HIAC, spectrophotometry, NIR, etc. The associate will be responsible for maintaining and testing stability samples (including frozen bulk, lyophilized drug product and formulation buffers). Experimentation may include IV administration studies along with time out of refrigeration analysis. Additional studies may include fill finish process development (e.g. mixing, filtration, filling and lyophilization), writing for frozen bulk development for technical report/manuscript, and development of NIR fiber optics for residual moisture analysis. Other responsibilities will include presentation of study results both inside and outside group.

The candidate must be self-motivated, with 3 to 6 years of experience, with a good understanding of protein biochemistry and biophysics.

*Please send resume on word document

Upload your resume here.

Our COVID-19 Policy

As with other larger employers and customer-facing organizations, Lenox Executive Search is carefully monitoring the situation regarding Coronavirus (COVID-19), with a particular focus on public health guidance offered by the CDC and state officials.  We are reaching out to make you aware of our activities and preparations in light of the spread of the Coronavirus (COVID-19). Our number one priority is the safety of our employees, clients and the broader community. Given the current unpredictable nature of the spread of COVID-19, and in an abundance of caution, Lenox Executive Search has implemented the following practices immediately:
  • We have increased our overnight cleaning activities to ensure frequently touched areas are being disinfected and sanitized.
  • We have implemented social distancing techniques to minimize the typical face-to-face- contact by utilizing teleconference calls and flexible workspaces.  We have suspended non-essential business travel for our employees and have asked that inter-company meetings be conducted via teleconference. In addition, we kindly ask all of our customers to help us maintain a handshake-free zone at all Lenox Executive Search locations.
  • We have asked employers who feel ill to stay home.
  • We have convened a team of senior leaders who meet daily to discuss the situation and stand ready to take additional steps, if necessary.
  • We have measures in place to ensure our operations can effectively continue so that we can provide our clients uninterrupted service.  Lenox Executive Search already had robust and detailed business continuity plans in place.
– The Lenox Executive Search Team